At Upstream Bio we strive to reach the source of inflammation and conquer it. Our lead program is a clinical-stage monoclonal antibody that inhibits the TSLP receptor. TSLP is a validated target positioned upstream of multiple signaling cascades that affect a variety of immune cells pivotal to common and rare diseases. We are leveraging our diverse roots and the team’s substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones.
View Top Employees from Upstream BioWebsite | http://www.upstreambio.com |
Revenue | $200000 |
Employees | 38 (28 on RocketReach) |
Founded | 2021 |
Address | 460 Totten Pond Rd, Waltham, Massachusetts 02451, US |
Phone | (713) 929-3863 |
Industry | Biotechnology Research, Business Services General, Business Services |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Upstream Bio employee's phone or email?
The Upstream Bio annual revenue was $200000 in 2024.
Samantha Truex is the CEO of Upstream Bio.
28 people are employed at Upstream Bio.
Upstream Bio is based in Waltham, Massachusetts.
The NAICS codes for Upstream Bio are [32541, 3254, 325, 32].
The SIC codes for Upstream Bio are [28, 283].